JUL 03, 2015 8:34 AM PDT

This will only hurt a little! Challenging the Theranos revolution

WRITTEN BY: Kerry Evans
Theranos, founded in 2003 by Elizabeth Holmes, plans to revolutionize clinical laboratory testing by offering low cost blood tests at neighborhood drug stores. Eleftherios Diamandis, head of clinical biochemistry at Mount Sinai Hospital in Toronto, thinks this is too good to be true. He challenges the Theranos model in a recent issue of Clinical Chemistry and Laboratory Medicine.

Theranos offers low cost, direct-to-consumer, laboratory testing.
Theranos testing requires just a few microliters of blood, and more than 30 tests can be performed on a single sample, according to Holmes. Blood is collected from the finger into a disposable cartridge, and loaded into a reader for analysis. However, according to Diamandis, this technology has not been independently evaluated, and no results have been shared in peer-reviewed scientific literature.

Theranos claims to offer the same services as a centralized laboratory, but at a fraction of the cost. Diamandis, however, suspects the cost of reagents and consumables to be similar, if not lower, at centralized labs. Theranos insists that a separate vial of blood is required by centralized labs to perform each blood test. Diamandis disagrees, noting that 10 to 100 analytes can be measured on a 7 ml sample of blood with current (low cost) technology.

Above all, Diamandis is most concerned about the public ordering and interpreting their own blood tests, citing a "lack of appreciation of the dangers of self-screening and self-interpretation of results by asymptomatic individuals who are trying to detect occult disease". What's more, centralized labs phased out the multi-parametric panels used by Theranos in the 1980s because they carry a high rate of false positive results.

Diamandis concludes his critique with a call to openly discuss the Theranos approach in the scientific literature. However, he maintains, "their claims of superiority over current systems and practices are speculative, at best".



Sources: Clinical Chemistry and Laboratory Medicine (CCLM). Volume 53, Issue 7, Pages 989-993 DOI: 10.1515/cclm-2015-0356, May 2015, Business Insider, EurekAlert, EmpowHER, Theranos
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
DEC 27, 2020
Immunology
A Fatty Diet can be Fuel for Tumor Growth!
DEC 27, 2020
A Fatty Diet can be Fuel for Tumor Growth!
Obesity is a significant problem in our societies with increasing the risk for many diseases, including cancer. Can ...
JAN 04, 2021
Microbiology
Some Microbes Could Help Treat Type 2 Diabetes
JAN 04, 2021
Some Microbes Could Help Treat Type 2 Diabetes
The microbial community in our gastrointestinal tract has been shown to have a significant impact on our health and well ...
JAN 06, 2021
Genetics & Genomics
Junk DNA Helps Control the Body Clock
JAN 06, 2021
Junk DNA Helps Control the Body Clock
Our bodies run on a kind of molecular clock, which helps regulate and time certain functions beyond just waking and slee ...
JAN 14, 2021
Clinical & Molecular DX
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
JAN 14, 2021
Tip of the Iceberg: Inaccuracies in Prostate Cancer Diagnostics
  Only 10 percent of icebergs are visible on the surface of the water; the remaining 90 percent remains submerged. ...
JAN 14, 2021
Health & Medicine
Cannabis Use May Affect Pregnancy Chances
JAN 14, 2021
Cannabis Use May Affect Pregnancy Chances
Some people find that pot can give their sex life a boost. But if you’re planning opt make a baby using cannabis m ...
JAN 24, 2021
Cell & Molecular Biology
A Protein That Restores Muscle Function and Doubles Capacity in Aged Mice
JAN 24, 2021
A Protein That Restores Muscle Function and Doubles Capacity in Aged Mice
Scientists have identified a hormone that is generated during exercise, and they determined that when mice are treated w ...
Loading Comments...